References
- French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1:107–115.
- Lenner R, Bregman Z, Teirstein AS, et al. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest. 2001;119:978–981.
- Gomez V, Smith PR, Burack J, et al. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2000;31:1278–1280.
- Naccache JM, Antoine M, Wislez M, et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med. 1999;159:2009–2013.
- Crum NF, Ganesan A, Johns ST, et al. Graves disease: an increasingly recognized immune reconstitution syndrome. Aids. 2006;20:466–469.
- Jubault V, Penfornis A, Schillo F, et al. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab. 2000;85:4254–4257.
- Diri E, Lipsky PE, Berggren RE. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol. 2000;27:2711–2714.
- Bell C, Nelson M, Kaye S. A case of immune reconstitution rheumatoid arthritis. Int J STD AIDS. 2002;13:580–581.
- Chen F, Day SL, Metcalfe RA, et al. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore). 2005;84:98–106.
- Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213.
- O'Leary JG, Zachary K, Misdraji J, et al. De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis. 2008;46:e12–e14.
- Puius YA, Dove LM, Brust DG, et al. Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol. 2008;42:425–429.
- Hagel S, Bruns T, Herrmann A, et al. Autoimmune hepatitis in an HIV-infected patient: an intriguing association. Int J STD AIDS. 2012;23:448–450.
- Wan DW, Marks K, Yantiss RK, et al. Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma. AIDS Patient Care STDs. 2009;23:407–413.
- Daas H, Khatib R, Nasser H, et al. Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature. J Med Case Rep. 2011;5:233.
- Cazanave C, Rakotondravelo S, Morlat P, et al. Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties. Rev Med Interne. 2006;27:414–419.
- Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938.
- Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.
- IRIS INftSoH-a. General IRIS Case Definition: University of Minnesota; [cited 2015 April 8]. Available from: http://www.inshi.umn.edu/definitions/General_IRIS/home.html.
- Hoffmann CJ, Charalambous S, Thio Cl, et al. Hepatotoxicity in an African Antiretroviral Therapy Cohort: the effect of tuberculosis and hepatitis B. Aids. 2007;21:1301–1308.
- Akhtar MA, Mathieson K, Arey B, et al. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol. 2008;20:1194–1204.
- Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958–976.
- Ofotokun I, Smithson SE, Lu C, et al. Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Am J Med Sci. 2007;334:334–341.
- Zhao L, Tang Y, You Z, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One. 2011;6:e18909.
- Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52:999–1007.